Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apotea AB (publ)CHIX:APOTES 18 Equity-to-Asset is 0.43 as of Jun. 2026, which is 16% above its 10-year median of 0.37. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 684 Healthcare Providers & Services companies, Apotea AB (publ) ranks worse than 55.85% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Apotea AB (publ)'s Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr947 Mil. Apotea AB (publ)'s Total Assets for the quarter that ended in Jun. 2026 was kr2,226 Mil.
Therefore, Apotea AB (publ)'s Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.43.
The historical rank and industry rank for Apotea AB (publ)'s Equity-to-Asset or its related term are showing as below:
CHIX:APOTEs'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26 Med: 0.37 Max: 0.43
Current: 0.43
During the past 5 years, the highest Equity to Asset Ratio of Apotea AB (publ) was 0.43. The lowest was 0.26. And the median was 0.37.
CHIX:APOTEs's Equity-to-Asset is ranked worse than 55.85% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs CHIX:APOTEs: 0.43
Apotea AB (publ) (CHIX:APOTEs) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Apotea AB (publ) Equity-to-Asset Related Terms
Apotea AB (publ) Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Equity-to-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Apotea AB (publ)'s Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (CHIX:APOTES) has a Equity-to-Asset of 0.43 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Apotea AB (publ) and its competitors. This is 16% above median its historical median of 0.37. Over the past decade, Apotea AB (publ)'s Equity-to-Asset has ranged from 0.26 to 0.43. According to the industry distribution chart, Apotea AB (publ) ranks #382 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 55.8%.
Is Apotea AB (publ)'s Equity-to-Asset too high?
Apotea AB (publ)'s current Equity-to-Asset of 0.43 is 16% above median its 10-year median of 0.37. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 0.43. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Apotea AB (publ)'s value of 0.43 is 10.4% below this industry median. Based on the distribution chart, Apotea AB (publ) ranks #382 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Equity-to-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #382 out of 684 companies for Equity-to-Asset. This places Apotea AB (publ) in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Apotea AB (publ)'s value of 0.43 is 10.4% below this benchmark. Historically, Apotea AB (publ)'s own Equity-to-Asset has ranged from 0.26 to 0.43 over the past decade. While the company's 10-year median is 0.37 vs. the industry median of 0.48, Apotea AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current Equity-to-Asset of 0.43 is 10.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Equity-to-Asset is 0.43, which is 16% above median its own 10-year median of 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Equity-to-Asset of 0.43. The current Equity-to-Asset is 0.43, which is 16% above median its 10-year median of 0.37 and 10.4% below the Healthcare Providers & Services industry median of 0.48. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Equity-to-Asset is 0.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for CHIX:APOTES
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:APOTES has been successfully added to your 
